Literature DB >> 8261071

Age, sex, cigarette smoking and indices of free radical activity in healthy humans.

A B Bridges1, N A Scott, G J Parry, J J Belch.   

Abstract

OBJECTIVES: To determine the effect of age, sex and smoking on free radical (FR) indices. There is currently considerable research interest into the role of FRs in the pathogenesis of many diseases and it is therefore important to identify factors in healthy subjects which influence the markers used to assess FR activity.
METHODS: Blood samples were obtained from 123 healthy subjects whose age, sex and smoking habits were recorded. The following were measured on each sample: malondialdehyde (MDA) which is a product of FR mediated lipid peroxidation and the FR scavengers plasma thiols (PSH), red cell glutathione (GSH) and superoxide dismutase (SOD).
RESULTS: Malondialdehyde levels were significantly increased in cigarette smokers (p < 0.02) but no significant age related increase in MDA was detected for the group as a whole. However, female smokers had the highest rate of MDA increase with age followed by male smokers and female non-smokers. MDA levels of male non-smokers were unaffected by age. A significant negative correlation was detected between PSH and age (p < 0.001). GSH was significantly higher in females (p < 0.05) and the red cell content of GSH and SOD were significantly inversely related (p < 0.01).
CONCLUSION: This study of normal subjects describes an age related increase in malondialdehyde levels, the rate of which is influenced by sex and smoking status. In humans, plasma thiol levels decrease with increasing age, females have higher red cell glutathione and there is a significant inverse relationship between red blood cell superoxide dismutase and glutathione levels. Furthermore, cigarette smoking increases plasma malondialdehyde levels. With the considerable current interest in free radicals, it is important to identify factors which influence the indices used to assess free radical activity in disease states.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261071

Source DB:  PubMed          Journal:  Eur J Med        ISSN: 1165-0478


  10 in total

Review 1.  Oxidants/antioxidants in idiopathic pulmonary fibrosis.

Authors:  W MacNee; I Rahman
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

2.  Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?

Authors:  I Rahman; E Swarska; M Henry; J Stolk; W MacNee
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

3.  Infection and smoking are associated with decreased plasma concentration of the anti-aging protein, α-klotho.

Authors:  Jennifer Lam-Rachlin; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Edgar Hernandez-Andrade; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

4.  Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids.

Authors:  Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2002

Review 5.  Antioxidant therapeutic advances in COPD.

Authors:  Irfan Rahman
Journal:  Ther Adv Respir Dis       Date:  2008-12       Impact factor: 4.031

Review 6.  Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer.

Authors:  Andrew W Caliri; Stella Tommasi; Ahmad Besaratinia
Journal:  Mutat Res Rev Mutat Res       Date:  2021-01-11       Impact factor: 5.657

7.  Oxidative Stress Function in Women over 40 Years of Age, Considering Their Lifestyle.

Authors:  Maria Paula Gonçalves Mota; Zirlene Santos; Jorge Soares; Ana Pereira; Sandra Fonseca; Francisco Peixoto; Isabel Gaivão; Maria Oliveira
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-16       Impact factor: 5.555

Review 8.  Antioxidant therapies in COPD.

Authors:  Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 9.  Future therapeutic treatment of COPD: struggle between oxidants and cytokines.

Authors:  Willem I de Boer; Hongwei Yao; Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Effects of Panax ginseng and ginsenosides on oxidative stress and cardiovascular diseases: pharmacological and therapeutic roles.

Authors:  Sun Hee Hyun; Kiran D Bhilare; Gyo In; Chae-Kyu Park; Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2021-07-26       Impact factor: 6.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.